Funding Opportunities

Instructions to NIH Intramural Investigators for Requesting Funds Using the PHS 398 Application
(Requires the free Adobe Reader)

Genetics Program

Notices

Administrative Supplements for Gene Identification Efforts: Replication and Fine-Mapping Studies for The Genes, Environment, and Health Initiative (GEI)
(NOT-CA-08-011)
National Cancer Institute (NCI)

Notice of Change in Receipt Date for RFA-MH-08-040, Methods of Statistical Analysis of DNA Sequence Data for Studies Relating Variation to Disease (R01)
(NOT-MH-07-120)
National Institute of Mental Health (NIMH)

Genome-wide Association Studies in the Genes and Environment Initiative – Availability of Additional Information
(NOT-HG-07-001)
National Institutes of Health

Genes and Environment Initiative – Participation of NIH Intramural Investigators
(NOT-OD-07-006)
National Institutes of Health

Requests for Applications

Informing Systems Biology through Genetic Variation: The Genes, Environment and Health Initiative (R21)
(RFA-MH-09-120)
Letters of Intent Receipt Date(s): December 14, 2008
Application Receipt Date: January 14, 2009

Replication and Fine-Mapping Studies for the Genes, Environment, and Health Initiative (GEI) (R01)
(RFA-CA-09-003)
National Institutes of Health
Letters of Intent Receipt Date(s): October 24, 2008
Application Receipt Date: December 1, 2008

Implementation Planning Grants for Educational, Behavioral, or Social Studies for Translation of Genetic Factors in Common Diseases (U34)
(RFA-DK-08-003)
National Institutes of Health
Letters of Intent Receipt Date(s): October 24, 2008
Application Receipt Date(s): November 25, 2008

Translation of Common Disease Genetics into Clinical Applications (R21)
(RFA-DK-08-004)
National Institutes of Health
Letters of Intent Receipt Date(s): October 24, 2008
Application Receipt Date(s): November 25, 2008

Functional Characterization of Genetic Variants and Interactions: The Genes, Environment and Health Initiative (R21)
(RFA-DA-09-003)
National Institutes of Health
Letters of Intent Receipt Date(s): September 17, 2008
Application Receipt Date(s): October 17, 2008

Functional Characterization of Genetic Variants and Interactions: The Genes, Environment and Health Initiative (R03)
(RFA-DA-09-004)
National Institutes of Health
Letters of Intent Receipt Date(s): September 17, 2008
Application Receipt Date(s): October 17, 2008

View expired RFAs »

Exposure Biology Program

RFA-ES-06-011 – Environmental Sensors for Personal Exposure Assessment (U01)
Development of new technologies for measuring human contact exposure and internal dose to priority environmental chemical/biological agents (e.g., airborne particulates, reactive gases, microbial toxins, solvents, pesticides, and mold/microbial toxins) with temporal and spatial resolution.

RFA-ES-06-012 – Biological Response Indicators of Environmental Stress Centers (U54)
Development of Centers that integrate biological response indicators with the development of field deployable biosensors to track exposures from point of contact to biological response.

RFA-ES-06-013 – Biological Response Indicators of Environmental Stress (U01)
Development of biological response indicators reflecting components of key physiologic and pathogenic processes, such as oxidative stress, immune response and inflammation, epigenetics, DNA damage and apoptosis, endocrine disruption, and defects in drug metabolizing enzymes.

RFA-CA-07-032 – Improved Measures of Diet and Physical Activity for the Genes and Environment Initiative (GEI) (U01)
Development of new technologies for measuring dietary/supplement intake and measures of physical activity using hand-held sensors, scanners or other devices, personal digital assistants (PDAs), imaging detection software, or wireless technology, and new technologies for measuring motion simultaneously with physiologic indicators of response (heart rate, respiration) with temporal and spatial resolution.

RFA-DA-07-005 – Field-Deployable Tools for Quantifying Exposures to Psychosocial Stress and to Addictive Substances for Studies of Health and Disease (U01)
Development of new technologies for measuring exposure to psychosocial stress and addictive substances usage including the use of hand-held devices for automated self-report and recall, innovative software, wireless technology, or other technology.

Up to Top